Shinn‐Chern Chen

1.0k total citations
38 papers, 831 citations indexed

About

Shinn‐Chern Chen is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Shinn‐Chern Chen has authored 38 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 32 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Shinn‐Chern Chen's work include Liver Disease Diagnosis and Treatment (32 papers), Hepatitis C virus research (28 papers) and Hepatitis B Virus Studies (14 papers). Shinn‐Chern Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Hepatitis C virus research (28 papers) and Hepatitis B Virus Studies (14 papers). Shinn‐Chern Chen collaborates with scholars based in Taiwan, China and United States. Shinn‐Chern Chen's co-authors include Wan‐Long Chuang, Chia‐Yen Dai, Ming‐Lung Yu, Jee‐Fu Huang, Zu‐Yau Lin, Ming‐Yen Hsieh, Liang‐Yen Wang, Chung‐Feng Huang, Ming‐Yuh Hsieh and Ming‐Lun Yeh and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Shinn‐Chern Chen

38 papers receiving 822 citations

Peers

Shinn‐Chern Chen
Shinn‐Chern Chen
Citations per year, relative to Shinn‐Chern Chen Shinn‐Chern Chen (= 1×) peers Ching‐I Huang

Countries citing papers authored by Shinn‐Chern Chen

Since Specialization
Citations

This map shows the geographic impact of Shinn‐Chern Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinn‐Chern Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinn‐Chern Chen more than expected).

Fields of papers citing papers by Shinn‐Chern Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinn‐Chern Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinn‐Chern Chen. The network helps show where Shinn‐Chern Chen may publish in the future.

Co-authorship network of co-authors of Shinn‐Chern Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shinn‐Chern Chen. A scholar is included among the top collaborators of Shinn‐Chern Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinn‐Chern Chen. Shinn‐Chern Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsai, Pei‐Chien, Chia‐Yen Dai, Ching‐I Huang, et al.. (2022). Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern Taiwan. The Kaohsiung Journal of Medical Sciences. 38(7). 694–702. 2 indexed citations
2.
Tsai, Pei‐Chien, Ching‐I Huang, Ming‐Lun Yeh, et al.. (2021). Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan. BMJ Open. 11(3). e042861–e042861. 12 indexed citations
3.
Huang, Chung‐Feng, Shufen Liu, Ming‐Lun Yeh, et al.. (2021). The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan. PLoS ONE. 16(1). e0246376–e0246376. 1 indexed citations
4.
Huang, Jee‐Fu, Chia‐Yen Dai, Chung‐Feng Huang, et al.. (2021). First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients. Hepatology International. 15(5). 1136–1147. 40 indexed citations
5.
Huang, Jee‐Fu, Pei‐Chien Tsai, Ming‐Lun Yeh, et al.. (2019). Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. Journal of the Formosan Medical Association. 119(1). 89–96. 37 indexed citations
6.
Yeh, Ming‐Lun, Chung‐Feng Huang, Ching‐I Huang, et al.. (2019). Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients. PLoS ONE. 14(8). e0220663–e0220663. 16 indexed citations
7.
Tsai, Jung‐Fa, Shinn‐Chern Chen, Zu‐Yau Lin, et al.. (2017). Interactive effects between Lymphotoxin α +252 polymorphism and habits of substance use on risk of hepatocellular carcinoma. The Kaohsiung Journal of Medical Sciences. 33(7). 334–338. 2 indexed citations
8.
Yeh, Ming‐Lun, Ching‐I Huang, Ming‐Yen Hsieh, et al.. (2016). Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open‐label, multicenter study. The Kaohsiung Journal of Medical Sciences. 32(11). 559–566. 2 indexed citations
9.
Jeng, Jen‐Eing, Huifang Wu, Zu‐Yau Lin, et al.. (2015). Independent and Additive Interaction Between Tumor Necrosis Factor β +252 Polymorphisms and Chronic Hepatitis B and C Virus Infection on Risk and Prognosis of Hepatocellular Carcinoma: a Case-Control Study. Asian Pacific Journal of Cancer Prevention. 15(23). 10209–10215. 8 indexed citations
10.
Jeng, Jen‐Eing, Lea‐Yea Chuang, Zu‐Yau Lin, et al.. (2014). Impact of Chronic Hepatitis B and Hepatitis C on Adverse Hepatic Fibrosis in Hepatocellular Carcinoma Related to Betel Quid Chewing. Asian Pacific Journal of Cancer Prevention. 15(2). 637–642. 21 indexed citations
11.
Dai, Chia‐Yen, Ming‐Lun Yeh, Chung‐Feng Huang, et al.. (2013). Chronic hepatitis C infection is associated with insulin resistance and lipid profiles. Journal of Gastroenterology and Hepatology. 30(5). 879–884. 54 indexed citations
12.
Jeng, Jen‐Eing, Lea‐Yea Chuang, Zu‐Yau Lin, et al.. (2013). Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma. Tumor Biology. 35(4). 3689–3698. 4 indexed citations
13.
Huang, Jee‐Fu, Chia‐Yen Dai, Ming‐Lung Yu, et al.. (2011). Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection. Hepatology Research. 41(5). 430–436. 11 indexed citations
14.
Huang, Jee‐Fu, Chung‐Feng Huang, Ming‐Lung Yu, et al.. (2010). Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection. Journal of Gastroenterology and Hepatology. 26(3). 530–535. 14 indexed citations
15.
Huang, Jee‐Fu, Wan‐Long Chuang, Ming‐Lung Yu, et al.. (2009). Hepatitis C Virus Infection And Metabolic Syndrome—A Community‐Based Study in an Endemic Area of Taiwan. The Kaohsiung Journal of Medical Sciences. 25(6). 299–305. 36 indexed citations
16.
Dai, Chia‐Yen, Jee‐Fu Huang, Ming‐Yen Hsieh, et al.. (2009). Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients. Journal of Hepatology. 50(4). 712–718. 122 indexed citations
17.
Huang, Jee‐Fu, Ming‐Lung Yu, Chia‐Yen Dai, et al.. (2008). Reappraisal of the Characteristics of Glucose Abnormalities in Patients With Chronic Hepatitis C Infection. The American Journal of Gastroenterology. 103(8). 1933–1940. 37 indexed citations
18.
Huang, Jee‐Fu, Chia‐Yen Dai, Y. Lin, et al.. (2008). Performance characteristics of a real-time RT-PCR assay for quantification of hepatitis C virus RNA in patients with genotype 1 and 2 infections. Clinical Chemistry and Laboratory Medicine (CCLM). 46(4). 475–80. 3 indexed citations
19.
Hsieh, Meng‐Hsuan, Li‐Po Lee, Ming‐Yen Hsieh, et al.. (2007). Hepatic Steatosis and Fibrosis in Chronic Hepatitis C in Taiwan. Japanese Journal of Infectious Diseases. 60(6). 377–381. 22 indexed citations
20.
Tsai, Jung‐Fa, Wen‐Yu Chang, Jen‐Eing Jeng, et al.. (1993). Hepatitis C virus infection as a risk factor for non‐alcoholic liver cirrhosis in taiwan. Journal of Medical Virology. 41(4). 296–300. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026